Elevance Health Inc. (0HG8.L)
USD 437.31
(4.63%)
USD 437.31
(4.63%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 23.24 Billion USD | 4.01% |
| 2022 | 22.34 Billion USD | 5.63% |
| 2021 | 21.15 Billion USD | 9.42% |
| 2020 | 19.33 Billion USD | 8.7% |
| 2019 | 17.78 Billion USD | 3.31% |
| 2018 | 17.21 Billion USD | -0.95% |
| 2017 | 17.38 Billion USD | 21.06% |
| 2016 | 14.35 Billion USD | -6.3% |
| 2015 | 15.32 Billion USD | 8.48% |
| 2014 | 14.12 Billion USD | 4.08% |
| 2013 | 13.57 Billion USD | -4.21% |
| 2012 | 14.17 Billion USD | 68.28% |
| 2011 | 8.42 Billion USD | 3.35% |
| 2010 | 8.14 Billion USD | -2.28% |
| 2009 | 8.33 Billion USD | 6.44% |
| 2008 | 7.83 Billion USD | -13.18% |
| 2007 | 9.02 Billion USD | 38.97% |
| 2006 | 6.49 Billion USD | 2.66% |
| 2005 | 6.32 Billion USD | 47.89% |
| 2004 | 4.27 Billion USD | 157.2% |
| 2003 | 1.66 Billion USD | 0.2% |
| 2002 | 1.65 Billion USD | 102.86% |
| 2001 | 818 Million USD | 36.9% |
| 2000 | 597.5 Million USD | 14.46% |
| 1999 | 522 Million USD | 72.9% |
| 1998 | 301.9 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 24.68 Billion USD | 0.52% |
| 2024 Q1 | 21.97 Billion USD | -5.46% |
| 2024 Q2 | 24.56 Billion USD | 11.76% |
| 2023 FY | 23.24 Billion USD | 4.01% |
| 2023 Q3 | 24.04 Billion USD | -3.27% |
| 2023 Q4 | 23.24 Billion USD | -3.32% |
| 2023 Q1 | 25.2 Billion USD | 12.76% |
| 2023 Q2 | 24.85 Billion USD | -1.36% |
| 2022 Q2 | 21.16 Billion USD | 6.45% |
| 2022 Q4 | 22.34 Billion USD | 5.13% |
| 2022 FY | 22.34 Billion USD | 5.63% |
| 2022 Q1 | 19.88 Billion USD | -6.02% |
| 2022 Q3 | 21.25 Billion USD | 0.44% |
| 2021 Q2 | 22.21 Billion USD | -1.41% |
| 2021 FY | 21.15 Billion USD | 9.42% |
| 2021 Q3 | 21.76 Billion USD | -2.05% |
| 2021 Q4 | 21.15 Billion USD | -2.78% |
| 2021 Q1 | 22.53 Billion USD | 16.55% |
| 2020 Q1 | 19 Billion USD | 6.85% |
| 2020 FY | 19.33 Billion USD | 8.7% |
| 2020 Q4 | 19.33 Billion USD | 1.26% |
| 2020 Q3 | 19.09 Billion USD | -3.92% |
| 2020 Q2 | 19.87 Billion USD | 4.57% |
| 2019 FY | 17.78 Billion USD | 3.31% |
| 2019 Q3 | 18.82 Billion USD | 7.94% |
| 2019 Q4 | 17.78 Billion USD | -5.49% |
| 2019 Q1 | 17.39 Billion USD | 1.04% |
| 2019 Q2 | 17.43 Billion USD | 0.23% |
| 2018 Q3 | 17.3 Billion USD | -1.23% |
| 2018 FY | 17.21 Billion USD | -0.95% |
| 2018 Q2 | 17.51 Billion USD | -3.28% |
| 2018 Q4 | 17.21 Billion USD | -0.48% |
| 2018 Q1 | 18.11 Billion USD | 4.19% |
| 2017 Q2 | 15.08 Billion USD | -2.34% |
| 2017 FY | 17.38 Billion USD | 21.06% |
| 2017 Q4 | 17.38 Billion USD | 26.17% |
| 2017 Q3 | 13.77 Billion USD | -8.69% |
| 2017 Q1 | 15.44 Billion USD | 7.6% |
| 2016 Q3 | 14.24 Billion USD | 0.28% |
| 2016 FY | 14.35 Billion USD | -6.3% |
| 2016 Q2 | 14.2 Billion USD | -4.45% |
| 2016 Q1 | 14.86 Billion USD | -3.0% |
| 2016 Q4 | 14.35 Billion USD | 0.82% |
| 2015 Q1 | 14.76 Billion USD | 4.51% |
| 2015 Q2 | 15.46 Billion USD | 4.77% |
| 2015 Q3 | 15.71 Billion USD | 1.62% |
| 2015 Q4 | 15.32 Billion USD | -2.51% |
| 2015 FY | 15.32 Billion USD | 8.48% |
| 2014 Q4 | 14.12 Billion USD | -2.83% |
| 2014 Q3 | 14.53 Billion USD | 3.57% |
| 2014 Q1 | 13.93 Billion USD | 2.64% |
| 2014 Q2 | 14.03 Billion USD | 0.76% |
| 2014 FY | 14.12 Billion USD | 4.08% |
| 2013 Q4 | 13.57 Billion USD | -6.48% |
| 2013 FY | 13.57 Billion USD | -4.21% |
| 2013 Q2 | 14.09 Billion USD | 0.44% |
| 2013 Q1 | 14.03 Billion USD | -0.99% |
| 2013 Q3 | 14.51 Billion USD | 3.0% |
| 2012 Q3 | 13.39 Billion USD | 32.16% |
| 2012 Q1 | 8.46 Billion USD | 0.49% |
| 2012 Q4 | 14.17 Billion USD | 5.79% |
| 2012 FY | 14.17 Billion USD | 68.28% |
| 2012 Q2 | 10.13 Billion USD | 19.77% |
| 2011 FY | 8.42 Billion USD | 3.35% |
| 2011 Q4 | 8.42 Billion USD | -2.34% |
| 2011 Q1 | 8.54 Billion USD | 4.84% |
| 2011 Q2 | 8.29 Billion USD | -2.93% |
| 2011 Q3 | 8.62 Billion USD | 3.98% |
| 2010 Q1 | 7.63 Billion USD | -8.49% |
| 2010 FY | 8.14 Billion USD | -2.28% |
| 2010 Q2 | 7.33 Billion USD | -3.87% |
| 2010 Q4 | 8.14 Billion USD | -0.84% |
| 2010 Q3 | 8.21 Billion USD | 12.03% |
| 2009 Q2 | 8.51 Billion USD | -0.16% |
| 2009 Q3 | 8.38 Billion USD | -1.52% |
| 2009 Q4 | 8.33 Billion USD | -0.55% |
| 2009 FY | 8.33 Billion USD | 6.44% |
| 2009 Q1 | 8.52 Billion USD | 8.85% |
| 2008 Q4 | 7.83 Billion USD | -7.74% |
| 2008 Q1 | 9.26 Billion USD | 2.69% |
| 2008 Q2 | 9.75 Billion USD | 5.22% |
| 2008 FY | 7.83 Billion USD | -13.18% |
| 2008 Q3 | 8.49 Billion USD | -12.91% |
| 2007 Q3 | 8.38 Billion USD | 9.52% |
| 2007 Q4 | 9.02 Billion USD | 7.67% |
| 2007 FY | 9.02 Billion USD | 38.97% |
| 2007 Q2 | 7.65 Billion USD | 16.2% |
| 2007 Q1 | 6.58 Billion USD | 1.42% |
| 2006 Q3 | 7.12 Billion USD | -4.35% |
| 2006 FY | 6.49 Billion USD | 2.66% |
| 2006 Q4 | 6.49 Billion USD | -8.83% |
| 2006 Q2 | 7.44 Billion USD | 11.74% |
| 2006 Q1 | 6.66 Billion USD | 5.36% |
| 2005 Q1 | 4.27 Billion USD | -0.08% |
| 2005 Q2 | 4 Billion USD | -6.16% |
| 2005 Q3 | 3.91 Billion USD | -2.29% |
| 2005 FY | 6.32 Billion USD | 47.89% |
| 2005 Q4 | 6.32 Billion USD | 61.42% |
| 2004 Q4 | 4.27 Billion USD | 181.29% |
| 2004 Q3 | 1.52 Billion USD | -8.66% |
| 2004 Q2 | 1.66 Billion USD | 0.05% |
| 2004 FY | 4.27 Billion USD | 157.2% |
| 2004 Q1 | 1.66 Billion USD | 0.05% |
| 2003 Q2 | 1.66 Billion USD | 0.05% |
| 2003 Q3 | 1.66 Billion USD | 0.05% |
| 2003 Q4 | 1.66 Billion USD | 0.05% |
| 2003 FY | 1.66 Billion USD | 0.2% |
| 2003 Q1 | 1.66 Billion USD | 0.05% |
| 2002 Q3 | 1.65 Billion USD | 102.43% |
| 2002 FY | 1.65 Billion USD | 102.86% |
| 2002 Q4 | 1.65 Billion USD | 0.05% |
| 2002 Q1 | 818.7 Million USD | 0.09% |
| 2002 Q2 | 819.3 Million USD | 0.07% |
| 2001 FY | 818 Million USD | 36.9% |
| 2001 Q4 | 818 Million USD | 36.84% |
| 2001 Q3 | 597.8 Million USD | 0.0% |
| 2000 FY | 597.5 Million USD | 14.46% |
| 1999 FY | 522 Million USD | 72.9% |
| 1998 FY | 301.9 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Phreesia, Inc. | 2.04 Million USD | -1134404.636% |
| Accuray Incorporated | 164.4 Million USD | -14039.903% |
| Align Technology, Inc. | 96.96 Million USD | -23872.857% |
| AxoGen, Inc. | 46.6 Million USD | -49780.909% |
| Boston Scientific Corporation | 8.56 Billion USD | -171.375% |
| CVS Health Corporation | 74.67 Billion USD | 68.869% |
| Cardinal Health, Inc. | 4.58 Billion USD | -407.222% |
| Centene Corporation | 17.69 Billion USD | -31.341% |
| DaVita Inc. | 8.05 Billion USD | -188.725% |
| HCA Healthcare, Inc. | 36.62 Billion USD | 36.535% |
| Hologic, Inc. | 2.49 Billion USD | -830.92% |
| Humana Inc. | 10.21 Billion USD | -127.612% |
| IDEXX Laboratories, Inc. | 622.88 Million USD | -3632.001% |
| Laboratory Corporation of America Holdings | 4.05 Billion USD | -473.31% |
| Masimo Corporation | 871.7 Million USD | -2566.743% |
| McKesson Corporation | 5.45 Billion USD | -326.454% |
| Patterson Companies, Inc. | 328.91 Million USD | -6967.565% |
| Quest Diagnostics Incorporated | 4.41 Billion USD | -427.12% |
| ResMed Inc. | 697.31 Million USD | -3233.654% |
| Henry Schein, Inc. | 1.93 Billion USD | -1102.587% |
| Teladoc Health, Inc. | 1.58 Billion USD | -1369.847% |
| Universal Health Services, Inc. | 4.71 Billion USD | -392.903% |
| Veeva Systems Inc. | 46.44 Million USD | -49954.908% |
| Baxter International Inc. | 11.06 Billion USD | -110.105% |
| Becton, Dickinson and Company | 14.73 Billion USD | -57.728% |
| Intuitive Surgical, Inc. | -82.1 Million USD | 28414.251% |
| Danaher Corporation | 17.66 Billion USD | -31.623% |
| Stryker Corporation | 10.9 Billion USD | -113.246% |
| Medtronic plc | 23.87 Billion USD | 2.643% |